跳转至内容
Merck
  • Transcription factors FOXG1 and Groucho/TLE promote glioblastoma growth.

Transcription factors FOXG1 and Groucho/TLE promote glioblastoma growth.

Nature communications (2013-12-21)
Federica Verginelli, Alessandro Perin, Rola Dali, Karen H Fung, Rita Lo, Pierluigi Longatti, Marie-Christine Guiot, Rolando F Del Maestro, Sabrina Rossi, Umberto di Porzio, Owen Stechishin, Samuel Weiss, Stefano Stifani
摘要

Glioblastoma (GBM) is the most common and deadly malignant brain cancer, with a median survival of <2 years. GBM displays a cellular complexity that includes brain tumour-initiating cells (BTICs), which are considered as potential key targets for GBM therapies. Here we show that the transcription factors FOXG1 and Groucho/TLE are expressed in poorly differentiated astroglial cells in human GBM specimens and in primary cultures of GBM-derived BTICs, where they form a complex. FOXG1 knockdown in BTICs causes downregulation of neural stem/progenitor and proliferation markers, increased replicative senescence, upregulation of astroglial differentiation genes and decreased BTIC-initiated tumour growth after intracranial transplantation into host mice. These effects are phenocopied by Groucho/TLE knockdown or dominant inhibition of the FOXG1:Groucho/TLE complex. These results provide evidence that transcriptional programmes regulated by FOXG1 and Groucho/TLE are important for BTIC-initiated brain tumour growth, implicating FOXG1 and Groucho/TLE in GBM tumourigenesis.

材料
货号
品牌
产品描述

Sigma-Aldrich
抗NeuN抗体,克隆A60, clone A60, Chemicon®, from mouse
Sigma-Aldrich
胶质纤维酸性蛋白(GFAP)单克隆抗体 小鼠抗, clone G-A-5, ascites fluid
Sigma-Aldrich
单克隆抗S-100(β-亚基) 小鼠抗, clone SH-B1, ascites fluid
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Foxg1